Lobbyists work against opiate reforms
(Geoff Mulvihill, Liz Essley Whyte and Ben Wieder, Associated Press and Center for Public Integrity 9:21 a.m. EDT September 19, 2016)
Makers of prescription painkillers have hundreds of lobbyists and millions in campaign contributions
The makers of prescription painkillers have adopted a 50-state strategy that includes hundreds of lobbyists and millions in campaign contributions to help kill or weaken measures aimed at stemming the tide of prescription opioids, the drugs at the heart of a crisis that has cost 165,000 Americans their lives and pushed countless more to crippling addiction.
The drugmakers vow they’re combatting the addiction epidemic, but the Associated Press and the Center for Public Integrity found that they often employ a statehouse playbook of delay and defend that includes funding advocacy groups that use the veneer of independence to fight limits on their drugs, such as OxyContin; Vicodin; and fentanyl, the narcotic linked to Prince’s death.
The industry and its allies spent more than $880 million nationwide on lobbying and campaign contributions from 2006 through 2015 – more than 200 times what those advocating for stricter policies spent and eight times more than the influential gun lobby recorded for similar activities during that same period, the AP and Center for Public Integrity found. (to read the complete AP Sourced article click on: Delaware Online )